Ilumya Injection and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Ilumya Injection and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Ilumya
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ilumya Injection-Moxifloxacin
- Ilumya Injection-Moxifloxacin (Systemic)
- Ilumya Injection-Moxifloxacin Hydrochloride
- Ilumya Injection-Moxifloxacin Injection
- Ilumya Injection-Moxifloxacin Intravenous
- Ilumya Injection-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Iluvien
- Moxetumomab pasudotox-tdfk Intravenous-Iluvien Implant
- Moxetumomab pasudotox-tdfk Intravenous-Imatinib
- Moxetumomab pasudotox-tdfk Intravenous-Imatinib Mesylate
- Moxetumomab pasudotox-tdfk Intravenous-Imbruvica
- Moxetumomab pasudotox-tdfk Intravenous-Imbruvica (Ibrutinib Capsules)